Allgens(SH:688613)2026-01-29 02:10Company Overview: 奥精医疗 (Aojing Medical) Key Points Industry and Company - The company operates in the orthopedic medical device industry, focusing on artificial bone products [1] Financial Performance - For 2025, the company forecasts revenue of 224 million yuan, representing a year-on-year increase of 8.48% [1] - The projected net profit attributable to shareholders is 13.53 million yuan, an increase of 26.19 million yuan year-on-year, indicating a turnaround from previous losses [1] - The non-recurring net profit is expected to be -510,000 yuan, an improvement of 2.786 million yuan year-on-year, significantly reducing losses [1] - In Q4 2025, the estimated revenue is 68 million yuan, showing a 17% year-on-year growth [1] - The projected net profit for Q4 2025 is -410,000 yuan, compared to -17.55 million yuan in Q4 2024 [1] - The non-recurring net profit for Q4 2025 is expected to be -361,000 yuan, an improvement from -2 million yuan in Q4 2024 [1] Market Dynamics - The orthopedic artificial bone procurement has provided the company with opportunities for continued clinical usage and market share expansion [2] - The company has strengthened its production assurance system to meet the increased demand resulting from procurement [3] - The marketing strategy focuses on deepening regional market strategies through refined management and targeted marketing, continuously expanding the sales network [3] Competitive Position - The company has demonstrated steady revenue growth throughout the year, further solidifying its leading position in the niche market [4]